Moore Capital Management »

Intra Cellular Therapies shares owned by Moore Capital Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 25k 71.62
2022-09-30 $8.4M 180k 46.53
2022-06-30 $11M 186k 57.08
2022-03-31 $4.8M 79k 61.19
2021-12-31 $4.2M 80k 52.34
2015-12-31 $2.4M 45k 53.80